学术活动

ACADEMIC ACTIVIYTIES
Image

TBSI湾区智荟讲堂第八十二讲丨博士后研讨会【清华深研院】

  1. 报告主题:Specific BAD Phosphorylation Inhibitor Combined with EGFR Inhibitors Effects in Adenocarcinoma of non-Small Cell Lung Cancer
  2. 报告人:Dr. Xi Zhang
  3. 主持:

时间

————————————

2019年1月10日(周四)15:00 – 16:00 p.m.



报告摘要

————————————

Targeting the epidermal growth factor receptor (EGFR) either alone or in combination with chemotherapy is effective for adenocarcinomatous non-small cell lung cancer patients in advanced stages with/without relapse or recurrence. However, not all of patients are sensitive to anti-EGFR therapy and even the best cases finally become refractory to this therapy. Therefore, discovery of a new combination strategies and novel mechanisms that contribute to both primary and acquired anti-EGFR therapy resistance to overcome or reverse this resistance is imperative. In this talk, Dr. Xi Zhang will characterize the anti-cancer efficacy of specific BAD phosphorylation inhibitor---NPB, and analyze the synergistic rationalities of combination strategies.



报告人简介

————————————

Xi Zhang, received her Ph.D. degree in Medicine from University of Munich (LMU), Germany, in 2018. Afterwards Dr. Xi Zhang joined Postdoctoral in the Precision Medicine and Healthcare Research Center, Tsinghua-Berkeley Shenzhen Institute, supervised by Prof. Peter E. Lobie. She has exceptionally experienced and proficient in her specialized area, including gynaecology, tumor biology, chemoprevention of cancer and inflammation-related diseases, and target therapy.


参与方式

————————————

欢迎TBSI各研究中心师生、社会公众及产业界人士参加。校外人员请扫描下方二维码登记信息(姓名、单位、联系电话、身份证号)。讲座语言为英文。